Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles

David Alan Preiss, M.D., Ph.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Bouhenguel JT, Preiss DA, Urman RD. Implementation and Use of Anesthesia Information Management Systems for Non-operating Room Locations. Anesthesiol Clin. 2017 Dec; 35(4):583-590. PMID: 29101948.
    View in: PubMed
  2. Sattar N, Toth PP, Blom DJ, Koren MJ, Soran H, Uhart M, Elliott M, Cyrille M, Somaratne R, Preiss D. Effect of the Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Evolocumab on Glycemia, Body Weight, and New-Onset Diabetes Mellitus. Am J Cardiol. 2017 Nov 01; 120(9):1521-1527. PMID: 28844508.
    View in: PubMed
  3. Sattar N, Preiss D. Reverse Causality in Cardiovascular Epidemiological Research: More Common Than Imagined? Circulation. 2017 Jun 13; 135(24):2369-2372. PMID: 28606949.
    View in: PubMed
  4. Toth PP, Descamps O, Genest J, Sattar N, Preiss D, Dent R, Djedjos C, Wu Y, Geller M, Uhart M, Somaratne R, Wasserman SM. Pooled Safety Analysis of Evolocumab in Over 6000 Patients From Double-Blind and Open-Label Extension Studies. Circulation. 2017 May 09; 135(19):1819-1831. PMID: 28249876.
    View in: PubMed
  5. Preiss D, Drew BA, Gosnell J, Kodali BS, Philip JH, Urman RD. Linshom thermodynamic sensor is a reliable alternative to capnography for monitoring respiratory rate. J Clin Monit Comput. 2018 Feb; 32(1):133-140. PMID: 28229352.
    View in: PubMed
  6. Kristensen SL, Mogensen UM, Jhund PS, Petrie MC, Preiss D, Win S, Køber L, McKelvie RS, Zile MR, Anand IS, Komajda M, Gottdiener JS, Carson PE, McMurray JJ. Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction). Circulation. 2017 Feb 21; 135(8):724-735. PMID: 28052977.
    View in: PubMed
  7. Preiss D, Mafham M. PCSK9 inhibition: the dawn of a new age in cholesterol lowering? Diabetologia. 2017 03; 60(3):381-389. PMID: 28025677.
    View in: PubMed
  8. Rankin NJ, Preiss D, Welsh P, Sattar N. Applying metabolomics to cardiometabolic intervention studies and trials: past experiences and a roadmap for the future. Int J Epidemiol. 2016 10; 45(5):1351-1371. PMID: 27789671.
    View in: PubMed
  9. Currie G, Taylor AH, Fujita T, Ohtsu H, Lindhardt M, Rossing P, Boesby L, Edwards NC, Ferro CJ, Townend JN, van den Meiracker AH, Saklayen MG, Oveisi S, Jardine AG, Delles C, Preiss DJ, Mark PB. Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis. BMC Nephrol. 2016 09 08; 17(1):127. PMID: 27609359; PMCID: PMC5015203.
  10. Brovman EY, Preiss D, Urman RD, Gross WL. The challenges of implementing electronic health records for anesthesia use outside the operating room. Curr Opin Anaesthesiol. 2016 Aug; 29(4):531-5. PMID: 27064215.
    View in: PubMed
  11. Sattar N, McLaren J, Kristensen SL, Preiss D, McMurray JJ. Erratum to: SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? Diabetologia. 2016 07; 59(7):1573-1574. PMID: 27174369.
    View in: PubMed
  12. Sattar N, Preiss D. Diabetic microvascular complications as simple indicators of risk for cardiovascular outcomes and heart failure. Lancet Diabetes Endocrinol. 2016 07; 4(7):555-6. PMID: 27216887.
    View in: PubMed
  13. Sattar N, McLaren J, Kristensen SL, Preiss D, McMurray JJ. SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? Diabetologia. 2016 07; 59(7):1333-1339. PMID: 27112340; PMCID: PMC4901113.
  14. Jackson CE, Haig C, Welsh P, Dalzell JR, Tsorlalis IK, McConnachie A, Preiss D, Anker SD, Sattar N, Petrie MC, Gardner RS, McMurray JJ. The incremental prognostic and clinical value of multiple novel biomarkers in heart failure. Eur J Heart Fail. 2016 12; 18(12):1491-1498. PMID: 27114189.
    View in: PubMed
  15. Sattar N, Preiss D. Screening for diabetes in patients with cardiovascular disease: HbA1c trumps oral glucose tolerance testing. Lancet Diabetes Endocrinol. 2016 07; 4(7):560-2. PMID: 27039357.
    View in: PubMed
  16. Nissen SE, Dent-Acosta RE, Rosenson RS, Stroes E, Sattar N, Preiss D, Mancini GB, Ballantyne CM, Catapano A, Gouni-Berthold I, Stein EA, Xue A, Wasserman SM, Scott R, Thompson PD. Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) Trial. Clin Cardiol. 2016 Mar; 39(3):137-44. PMID: 26946077.
    View in: PubMed
  17. Sattar N, Preiss D, Robinson JG, Djedjos CS, Elliott M, Somaratne R, Wasserman SM, Raal FJ. Lipid-lowering efficacy of the PCSK9 inhibitor evolocumab (AMG 145) in patients with type 2 diabetes: a meta-analysis of individual patient data. Lancet Diabetes Endocrinol. 2016 05; 4(5):403-10. PMID: 26868195.
    View in: PubMed
  18. Kristensen SL, Preiss D, Jhund PS, Squire I, Cardoso JS, Merkely B, Martinez F, Starling RC, Desai AS, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, McMurray JJ, Packer M. Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial. Circ Heart Fail. 2016 Jan; 9(1). PMID: 26754626; PMCID: PMC4718182.
  19. Loomis AK, Kabadi S, Preiss D, Hyde C, Bonato V, St Louis M, Desai J, Gill JM, Welsh P, Waterworth D, Sattar N. Body Mass Index and Risk of Nonalcoholic Fatty Liver Disease: Two Electronic Health Record Prospective Studies. J Clin Endocrinol Metab. 2016 Mar; 101(3):945-52. PMID: 26672639; PMCID: PMC4803162.
  20. Welsh P, Hart C, Papacosta O, Preiss D, McConnachie A, Murray H, Ramsay S, Upton M, Watt G, Whincup P, Wannamethee G, Sattar N. Prediction of Cardiovascular Disease Risk by Cardiac Biomarkers in 2 United Kingdom Cohort Studies: Does Utility Depend on Risk Thresholds For Treatment? Hypertension. 2016 Feb; 67(2):309-15. PMID: 26667414.
    View in: PubMed
  21. Goldie C, Taylor AJ, Nguyen P, McCoy C, Zhao XQ, Preiss D. Niacin therapy and the risk of new-onset diabetes: a meta-analysis of randomised controlled trials. Heart. 2016 Feb; 102(3):198-203. PMID: 26370223; PMCID: PMC4752613.
  22. Preiss D, Thomas LE, Wojdyla DM, Haffner SM, Gill JM, Yates T, Davies MJ, Holman RR, McMurray JJ, Califf RM, Kraus WE. Prospective relationships between body weight and physical activity: an observational analysis from the NAVIGATOR study. BMJ Open. 2015 Aug 14; 5(8):e007901. PMID: 26275900; PMCID: PMC4550730.
  23. Rush CJ, Campbell RT, Jhund PS, Connolly EC, Preiss D, Gardner RS, Petrie MC, McMurray JJ. Falling Cardiovascular Mortality in Heart Failure With Reduced Ejection Fraction and Implications for Clinical Trials. JACC Heart Fail. 2015 Aug; 3(8):603-14. PMID: 26251086.
    View in: PubMed
  24. Jackson CE, Haig C, Welsh P, Dalzell JR, Tsorlalis IK, McConnachie A, Preiss D, McInnes IB, Sattar N, Petrie MC, Gardner RS, McMurray JJ. Combined Free Light Chains Are Novel Predictors of Prognosis in Heart Failure. JACC Heart Fail. 2015 Aug; 3(8):618-25. PMID: 26251088.
    View in: PubMed
  25. Preiss D, Neely D. Biochemistry laboratories should routinely report non-HDL-cholesterol. Ann Clin Biochem. 2015 Nov; 52(Pt 6):629-31. PMID: 26085052.
    View in: PubMed
  26. Yates T, Davies MJ, Haffner SM, Schulte PJ, Thomas L, Huffman KM, Bales CW, Preiss D, Califf RM, Holman RR, McMurray JJ, Bethel MA, Tuomilehto J, Kraus WE. Physical activity as a determinant of fasting and 2-h post-challenge glucose: a prospective cohort analysis of the NAVIGATOR trial. Diabet Med. 2015 Aug; 32(8):1090-6. PMID: 25818859.
    View in: PubMed
  27. Preiss D, Campbell RT, Murray HM, Ford I, Packard CJ, Sattar N, Rahimi K, Colhoun HM, Waters DD, LaRosa JC, Amarenco P, Pedersen TR, Tikkanen MJ, Koren MJ, Poulter NR, Sever PS, Ridker PM, MacFadyen JG, Solomon SD, Davis BR, Simpson LM, Nakamura H, Mizuno K, Marfisi RM, Marchioli R, Tognoni G, Athyros VG, Ray KK, Gotto AM, Clearfield MB, Downs JR, McMurray JJ. The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials. Eur Heart J. 2015 Jun 21; 36(24):1536-46. PMID: 25802390; PMCID: PMC4769322.
  28. Preiss D, Sattar N. Does the LDL receptor play a role in the risk of developing type 2 diabetes? JAMA. 2015 Mar 10; 313(10):1016-7. PMID: 25756436.
    View in: PubMed
  29. Preiss D, Kristensen SL. The new pooled cohort equations risk calculator. Can J Cardiol. 2015 May; 31(5):613-9. PMID: 25843167.
    View in: PubMed
  30. Preiss D, Sattar N. Classification of reported statin intolerance. Curr Opin Lipidol. 2015 Feb; 26(1):65-6. PMID: 25551804.
    View in: PubMed
  31. Kristensen SL, Jhund PS, Køber L, Preiss D, Kjekshus J, McKelvie RS, Zile MR, Anand IS, Wikstrand J, Wedel H, Komajda M, Carson PE, Cleland JG, McMurray JJ. Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction. Eur J Heart Fail. 2015 Feb; 17(2):169-76. PMID: 25756844.
    View in: PubMed
  32. Preiss DA, Azami T, Urman RD. Variations in respiratory excretion of carbon dioxide can be used to calculate pulmonary blood flow. J Clin Med Res. 2015 Feb; 7(2):83-90. PMID: 25436024; PMCID: PMC4245058.
  33. Welsh P, Preiss D, Lloyd SM, de Craen AJ, Jukema JW, Westendorp RG, Buckley BM, Kearney PM, Briggs A, Stott DJ, Ford I, Sattar N. Contrasting associations of insulin resistance with diabetes, cardiovascular disease and all-cause mortality in the elderly: PROSPER long-term follow-up. Diabetologia. 2014 Dec; 57(12):2513-20. PMID: 25264116.
    View in: PubMed
  34. Rankin NJ, Preiss D, Welsh P, Burgess KE, Nelson SM, Lawlor DA, Sattar N. The emergence of proton nuclear magnetic resonance metabolomics in the cardiovascular arena as viewed from a clinical perspective. Atherosclerosis. 2014 Nov; 237(1):287-300. PMID: 25299963; PMCID: PMC4232363.
  35. Swerdlow DI, Preiss D, Kuchenbaecker KB, Holmes MV, Engmann JE, Shah T, Sofat R, Stender S, Johnson PC, Scott RA, Leusink M, Verweij N, Sharp SJ, Guo Y, Giambartolomei C, Chung C, Peasey A, Amuzu A, Li K, Palmen J, Howard P, Cooper JA, Drenos F, Li YR, Lowe G, Gallacher J, Stewart MC, Tzoulaki I, Buxbaum SG, van der A DL, Forouhi NG, Onland-Moret NC, van der Schouw YT, Schnabel RB, Hubacek JA, Kubinova R, Baceviciene M, Tamosiunas A, Pajak A, Topor-Madry R, Stepaniak U, Malyutina S, Baldassarre D, Sennblad B, Tremoli E, de Faire U, Veglia F, Ford I, Jukema JW, Westendorp RG, de Borst GJ, de Jong PA, Algra A, Spiering W, Maitland-van der Zee AH, Klungel OH, de Boer A, Doevendans PA, Eaton CB, Robinson JG, Duggan D, Kjekshus J, Downs JR, Gotto AM, Keech AC, Marchioli R, Tognoni G, Sever PS, Poulter NR, Waters DD, Pedersen TR, Amarenco P, Nakamura H, McMurray JJ, Lewsey JD, Chasman DI, Ridker PM, Maggioni AP, Tavazzi L, Ray KK, Seshasai SR, Manson JE, Price JF, Whincup PH, Morris RW, Lawlor DA, Smith GD, Ben-Shlomo Y, Schreiner PJ, Fornage M, Siscovick DS, Cushman M, Kumari M, Wareham NJ, Verschuren WM, Redline S, Patel SR, Whittaker JC, Hamsten A, Delaney JA, Dale C, Gaunt TR, Wong A, Kuh D, Hardy R, Kathiresan S, Castillo BA, van der Harst P, Brunner EJ, Tybjaerg-Hansen A, Marmot MG, Krauss RM, Tsai M, Coresh J, Hoogeveen RC, Psaty BM, Lange LA, Hakonarson H, Dudbridge F, Humphries SE, Talmud PJ, Kivimäki M, Timpson NJ, Langenberg C, Asselbergs FW, Voevoda M, Bobak M, Pikhart H, Wilson JG, Reiner AP, Keating BJ, Hingorani AD, Sattar N. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials. Lancet. 2015 Jan 24; 385(9965):351-61. PMID: 25262344.
    View in: PubMed
  36. Preiss D. Do statins reduce microvascular complications in diabetes? Lancet Diabetes Endocrinol. 2014 Nov; 2(11):858-9. PMID: 25217179.
    View in: PubMed
  37. Sattar N, Forrest E, Preiss D. Non-alcoholic fatty liver disease. BMJ. 2014 Jul 29; 349:g4596. PMID: 25239614; PMCID: PMC4168663.
  38. Preiss D, Packard CJ. Emerging therapeutic approaches to treat dyslipidemia. Curr Cardiol Rep. 2014 Jul; 16(7):506. PMID: 24890766.
    View in: PubMed
  39. Preiss D, Haffner SM, Thomas LE, Sun JL, Sattar N, Yates T, J Davies M, McMurray JJ, Holman RR, Califf RM, Kraus WE. Change in levels of physical activity after diagnosis of type 2 diabetes: an observational analysis from the NAVIGATOR study. Diabetes Obes Metab. 2014 Dec; 16(12):1265-8. PMID: 24861892.
    View in: PubMed
  40. Preiss D, McMurray JJ, Sattar N. Treatment of severe hypertriglyceridaemia. Lancet Diabetes Endocrinol. 2014 Nov; 2(11):860. PMID: 25439459.
    View in: PubMed
  41. Preiss D, Sattar N. Choice of medical therapy to lower triglycerides in those at risk of pancreatitis. Curr Opin Lipidol. 2013 Dec; 24(6):532-3. PMID: 24231280.
    View in: PubMed
  42. Preiss D, Lloyd SM, Ford I, McMurray JJ, Holman RR, Welsh P, Fisher M, Packard CJ, Sattar N. Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial. Lancet Diabetes Endocrinol. 2014 Feb; 2(2):116-24. PMID: 24622715.
    View in: PubMed
  43. Preiss D, Giles TD, Thomas LE, Sun JL, Haffner SM, Holman RR, Standl E, Mazzone T, Rutten GE, Tognoni G, Chiang FT, McMurray JJ, Califf RM. Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial. Stroke. 2013 Sep; 44(9):2590-3. PMID: 23899915.
    View in: PubMed
  44. Perez AC, Jhund P, Preiss D, Kjekshus J, McMurray JJ. Effect of rosuvastatin on fatigue in patients with heart failure. J Am Coll Cardiol. 2013 Mar 12; 61(10):1121-2. PMID: 23473415.
    View in: PubMed
  45. Preiss D, Thomas LE, Sun JL, Haffner SM, Holman RR, Standl E, Leiter LA, Mazzone T, Rutten GE, Tognoni G, Martinez FA, Chiang FT, Califf RM, McMurray JJ. Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial. BMJ Open. 2012; 2(6). PMID: 23204139; PMCID: PMC3533049.
  46. Preiss D, Tikkanen MJ, Welsh P, Ford I, Lovato LC, Elam MB, LaRosa JC, DeMicco DA, Colhoun HM, Goldenberg I, Murphy MJ, MacDonald TM, Pedersen TR, Keech AC, Ridker PM, Kjekshus J, Sattar N, McMurray JJ. Lipid-modifying therapies and risk of pancreatitis: a meta-analysis. JAMA. 2012 Aug 22; 308(8):804-11. PMID: 22910758.
    View in: PubMed
  47. Preiss D, van Veldhuisen DJ, Sattar N, Krum H, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B, Zannad F, McMurray JJ. Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF). Eur J Heart Fail. 2012 Aug; 14(8):909-15. PMID: 22611047.
    View in: PubMed
  48. Sattar N, Preiss D. HbA1c in type 2 diabetes diagnostic criteria: addressing the right questions to move the field forwards. Diabetologia. 2012 Jun; 55(6):1564-7. PMID: 22398646.
    View in: PubMed
  49. Preiss D, Sattar N. Statins and the risk of new-onset diabetes: a review of recent evidence. Curr Opin Lipidol. 2011 Dec; 22(6):460-6. PMID: 21897230.
    View in: PubMed
  50. Ford I, Mooijaart SP, Lloyd S, Murray HM, Westendorp RG, de Craen AJ, Packard CJ, Buckley B, Barlow C, Preiss D, Cobbe SM, Stott DJ, Sattar N. The inverse relationship between alanine aminotransferase in the normal range and adverse cardiovascular and non-cardiovascular outcomes. Int J Epidemiol. 2011 Dec; 40(6):1530-8. PMID: 22158663.
    View in: PubMed
  51. Preiss D, Sattar N. The case for diabetes screening: ADDITION-Europe. Lancet. 2011 Jul 09; 378(9786):106-8. PMID: 21705070.
    View in: PubMed
  52. Preiss D, Seshasai SR, Welsh P, Murphy SA, Ho JE, Waters DD, DeMicco DA, Barter P, Cannon CP, Sabatine MS, Braunwald E, Kastelein JJ, de Lemos JA, Blazing MA, Pedersen TR, Tikkanen MJ, Sattar N, Ray KK. Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA. 2011 Jun 22; 305(24):2556-64. PMID: 21693744.
    View in: PubMed
  53. Preiss D, Sattar N, McMurray JJ. A systematic review of event rates in clinical trials in diabetes mellitus: the importance of quantifying baseline cardiovascular disease history and proteinuria and implications for clinical trial design. Am Heart J. 2011 Jan; 161(1):210-219.e1. PMID: 21167356.
    View in: PubMed
  54. Preiss D, Khunti K, Sattar N. Combined cardiovascular and diabetes risk assessment in primary care. Diabet Med. 2011 Jan; 28(1):19-22. PMID: 21210538.
    View in: PubMed
  55. Preiss D, Sattar N. HbA1c: a useful cardiovascular risk marker in those without diabetes? Diabetologia. 2010 Dec; 53(12):2468-9. PMID: 20835700.
    View in: PubMed
  56. Ghouri N, Preiss D, Sattar N. Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data. Hepatology. 2010 Sep; 52(3):1156-61. PMID: 20658466.
    View in: PubMed
  57. Preiss D, Sattar N, McMurray JJ. Event rates in trials of patients with type 2 diabetes. JAMA. 2010 Feb 24; 303(8):732-3; author reply 733. PMID: 20179281.
    View in: PubMed
  58. Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ, Seshasai SR, McMurray JJ, Freeman DJ, Jukema JW, Macfarlane PW, Packard CJ, Stott DJ, Westendorp RG, Shepherd J, Davis BR, Pressel SL, Marchioli R, Marfisi RM, Maggioni AP, Tavazzi L, Tognoni G, Kjekshus J, Pedersen TR, Cook TJ, Gotto AM, Clearfield MB, Downs JR, Nakamura H, Ohashi Y, Mizuno K, Ray KK, Ford I. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet. 2010 Feb 27; 375(9716):735-42. PMID: 20167359.
    View in: PubMed
  59. Ray KK, Seshasai SR, Wijesuriya S, Sivakumaran R, Nethercott S, Preiss D, Erqou S, Sattar N. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet. 2009 May 23; 373(9677):1765-72. PMID: 19465231.
    View in: PubMed
  60. Preiss D, Sattar N. Metabolic syndrome: collapsing under its own weight? Diabet Med. 2009 May; 26(5):457-9. PMID: 19646182.
    View in: PubMed
  61. Preiss D, Zetterstrand S, McMurray JJ, Ostergren J, Michelson EL, Granger CB, Yusuf S, Swedberg K, Pfeffer MA, Gerstein HC, Sattar N. Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program. Diabetes Care. 2009 May; 32(5):915-20. PMID: 19196892; PMCID: PMC2671104.
  62. Preiss D, Sattar N. Lipids, lipid modifying agents and cardiovascular risk: a review of the evidence. Clin Endocrinol (Oxf). 2009 Jun; 70(6):815-28. PMID: 19067719.
    View in: PubMed
  63. Preiss D, Sattar N. Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. Clin Sci (Lond). 2008 Sep; 115(5):141-50. PMID: 18662168.
    View in: PubMed
  64. Preiss D, Fisher J. A measure of confidence in Bland-Altman analysis for the interchangeability of two methods of measurement. J Clin Monit Comput. 2008 Aug; 22(4):257-9. PMID: 18607545.
    View in: PubMed
  65. Somogyi RB, Vesely AE, Preiss D, Prisman E, Volgyesi G, Azami T, Iscoe S, Fisher JA, Sasano H. Precise control of end-tidal carbon dioxide levels using sequential rebreathing circuits. Anaesth Intensive Care. 2005 Dec; 33(6):726-32. PMID: 16398376.
    View in: PubMed
  66. Simchen MJ, Tesler J, Azami T, Preiss D, Fedorko L, Goldszmidz E, Fisher J, Kingdom J, Slorach C, Hornberger LK. Effects of maternal hyperoxia with and without normocapnia in uteroplacental and fetal Doppler studies. Ultrasound Obstet Gynecol. 2005 Oct; 26(5):495-9. PMID: 16180259.
    View in: PubMed
  67. Azami T, Preiss D, Somogyi R, Vesely A, Prisman E, Iscoe S, De Wolf AM, Fisher JA. Calculation of O2 consumption during low-flow anesthesia from tidal gas concentrations, flowmeter, and minute ventilation. J Clin Monit Comput. 2004 Dec; 18(5-6):325-32. PMID: 15957623.
    View in: PubMed
  68. Somogyi R, Vesely AE, Azami T, Preiss D, Fisher J, Correia J, Fowler RA. Dispersal of respiratory droplets with open vs closed oxygen delivery masks: implications for the transmission of severe acute respiratory syndrome. Chest. 2004 Mar; 125(3):1155-7. PMID: 15006983.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Preiss's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (254)
Explore
_
Co-Authors (19)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_